1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
- 2015
-
Mark
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Efficient and reproducible identification of mismatch repair deficient colon cancer : Validation of the MMR index and comparison with other predictive models
(
- Contribution to journal › Article
-
Mark
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
(
- Contribution to journal › Article
- 2009
-
Mark
Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
(
- Contribution to journal › Article
- 2008
-
Mark
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
(
- Contribution to journal › Article